Insiders · LWAC

LWAC insider transactions

LightWave Acquisition Corp. (LWAC) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for LWAC

• 291d
  SEC Form 3 filed by new insider Dickason Allen Charles

  3 - LightWave Acquisition Corp. (0002061379) (Issuer)
• 291d
  Large owner Lightwave Founders Llc bought $6,062,500 worth of Class A ordinary shares (606,250 units at $10.00) (SEC Form 4)

  4 - LightWave Acquisition Corp. (0002061379) (Issuer)
• 305d
  SEC Form 3 filed by new insider Lightwave Founders Llc

  3 - LightWave Acquisition Corp. (0002061379) (Issuer)
• 305d
  SEC Form 3 filed by new insider Bunker William Whithorne Jr

  3 - LightWave Acquisition Corp. (0002061379) (Issuer)
• 305d
  SEC Form 3 filed by new insider Blechman Charlotte

  3 - LightWave Acquisition Corp. (0002061379) (Issuer)
• 305d
  SEC Form 3 filed by new insider Hochberg Robert

  3 - LightWave Acquisition Corp. (0002061379) (Issuer)
• 1660d
  SEC Form 4 filed by Ehrlich Christopher B

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1660d
  SEC Form 4 filed by Bhatt Elizabeth

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1660d
  SEC Form 4 filed by Smither John W

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1660d
  SEC Form 4 filed by Root Jonathan D

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1660d
  SEC Form 4 filed by Lasky Laurence

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1660d
  SEC Form 4 filed by Gallagher Brian M. Jr.

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1691d
  SEC Form 3: New insider Column Group Ii Gp, Lp claimed ownership of 4,309,329 units of Common Stock

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1697d
  SEC Form 3: New insider Sr One Capital Management, Llc claimed ownership of 6,822,114 units of Common Stock

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 3: New insider Presidio Management Group X Llc claimed ownership of 4,822,114 units of Common Stock

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 4: Root Jonathan D was granted 4,822,114 units of Common Stock

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 4: Ehrlich Christopher B converted options into 143,202 units of Common Stock

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 3 filed by new insider Root Jonathan D

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 4: Bhatt Elizabeth converted options into 9,047 units of Class A Common Stock

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 4: Gallagher Brian M. Jr. was granted 4,822,114 units of Common Stock

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 3 filed by new insider Gallagher Brian M. Jr.

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 3 filed by new insider Lasky Laurence

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 3: New insider Abingworth Llp claimed ownership of 4,822,114 units of Common Stock

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 4: Locust Walk Sponsor, Llc converted options into 3,511,250 units of Common Stock, increasing direct ownership by 644% to 4,056,250 units

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 4: Smither John W was granted 24,142 units of Common Stock

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 3 filed by new insider Smither John W

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 4 filed by Patel Premal

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 3 filed by new insider Patel Premal

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 4: Mcnulty Alana B. was granted 48,768 units of Common Stock

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 3 filed by new insider Mcnulty Alana B.

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 4 filed by Byrnes Michael

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 4: Worland Stephen T was granted 755,480 units of Common Stock, increasing direct ownership by 34% to 755,480 units

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 3 filed by new insider Byrnes Michael

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1702d
  SEC Form 3 filed by new insider Worland Stephen T

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)